Arcutis Biotherapeutics Inc. (ARQT)
NASDAQ · Healthcare
Arcutis Biotherapeutics Inc. Long Term Debt 2020–2025
Arcutis Biotherapeutics Inc. annual/quarterly long term debt history from 2021 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Arcutis Biotherapeutics Inc. long term debt for the quarter ending December 31, 2025 were 109.0M, a 1.64% increase year-over-year.
- Arcutis Biotherapeutics Inc. long term debt for 2025 were 109.0M, a 1.64% increase from 2024.
- Arcutis Biotherapeutics Inc. long term debt for 2024 were 107.2M, a 46.88% decrease from 2023.
- Arcutis Biotherapeutics Inc. long term debt for 2023 were 201.8M, a 2.04% increase from 2022.
- Arcutis Biotherapeutics Inc. long term debt for 2022 were 197.8M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Arcutis Biotherapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $109 |
| 2024 | $107 |
| 2023 | $202 |
| 2022 | $198 |
| 2021 | $72 |
| Arcutis Biotherapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $109 |
| 2024-12-31 | $107 |
| 2023-12-31 | $202 |
| 2022-12-31 | $198 |
| 2021-12-31 | $72 |
Arcutis Biotherapeutics Inc. Long Term Debt — FAQ
Arcutis Biotherapeutics Inc. (ARQT) long term debt over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ARQT's long term debt history?
The chart and table above show Arcutis Biotherapeutics Inc.'s long term debt by year and by quarter, including the growth rate.